Alefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells

S. Lee, Y. Yamada, M. Tonsho, S. Boskovic, O. Nadazdin, D. Schoenfeld, K. Cappetta, M. Atif, R. N. Smith, A. B. Cosimi, G. Benichou, T. Kawai

研究成果: Article査読

28 被引用数 (Scopus)

抄録

Renal allograft tolerance has been achieved in MHC-mismatched primates via nonmyeloablative conditioning beginning 6 days prior to planned kidney and donor bone marrow transplantation (DBMT). To extend the applicability of this approach to deceased donor transplantation, we recently developed a novel-conditioning regimen, the "delayed protocol" in which donor bone marrow (DBM) is transplanted several months after kidney transplantation. However, activation/expansion of donor-reactive CD8+ memory T cells (TMEM) occurring during the interval between kidney and DBM transplantation impaired tolerance induction using this strategy. In the current study, we tested whether, Alefacept, a fusion protein which targets LFA-3/CD2 interactions and selectively depletes CD2highCD8+ effector memory T cells (TEM) could similarly induce long-term immunosuppression-free renal allograft survival but avoid the deleterious effects of anti-CD8 mAb treatment. We found that Alefacept significantly delayed the expansion of CD2 high cells including CD8+ TEM while sparing naïve CD8+ T and NK cells and achieved mixed chimerism and long-term immunosuppression-free renal allograft survival. In conclusion, elimination of CD2high T cells represents a promising approach to prevent electively the expansion/activation of donor-reactive TEM and promotes tolerance induction via the delayed protocol mixed chimerism approach. The authors show that alefacept significantly delays the expansion of CD2high memory T cells and promotes mixed chimerism and immunosuppression-free renal allograft survival in a primate model of delayed tolerance induction.

本文言語English
ページ(範囲)3223-3229
ページ数7
ジャーナルAmerican Journal of Transplantation
13
12
DOI
出版ステータスPublished - 2013 12月
外部発表はい

ASJC Scopus subject areas

  • 免疫アレルギー学
  • 移植
  • 薬理学(医学)

フィンガープリント

「Alefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル